Biopharm Business - BioPharm International

ADVERTISEMENT

Biopharm Business
Insight and analysis to business aspects of biopharmaceutical development. Mergers, acquisitions, legal activities.

A New Way to Think About Outsourcing Partnerships

May 1, 2012

Future sponsor-contract provider relationships will require more integration.

Some Supply Chain Lessons Can Go a Long Way

May 1, 2012

No matter the time or cost, knowing what's going on inside your facilities is always going to be worth the effort.

The Growing Orphan-Drug Paradigm

April 1, 2012

Rather than seeking a single indication for one large group, the orphan-drug approach segments the market for a drug more minutely.

Manufacturers Wrestle with Drug Abuse and Critical Shortages

April 1, 2012

Soaring opioid use creates challenges for new drug development and supply-chain control.

Knowledge Management Implementation

April 1, 2012

The authors discuss the technology and guidance required to achieve good KM in a biopharmaceutical company.

PDA Tackles Changing Industry Times

April 1, 2012

The confluence of science, technology, and regulation will provide our industry with the guidance to move forward.

A Strong Start to 2012

April 1, 2012

Better news about the global economy buoys life-sciences funding.

Small Changes, System-Wide Impact

April 1, 2012

A closer look at elastomer changeout times provides one example of using industry knowledge to improve operations and cost.

Preparing for an FDA Inspection in a Global Pharmaceutical Environment

April 1, 2012

FDA has created a dedicated cadre of foreign drug investigators and established permanent offices worldwide.

ADVERTISEMENT

ADVERTISEMENT

Click here